That's in animals in 2022. We've seen pretty good pre-clinical data already, but it's results in IPF patients that we won't see til the middle of FY24 now.
It's that part of the phase I that I had really been looking forward to, now it's canceled.
1AD Price at posting:
9.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)